首页> 外国专利> - - Gene Therapeutic Agent of Cancer Comprising Recombinant Adeno-associated Virus Containing Antisense cDNAs of VEGF-A VEGF-B and VEGF-C and Recombinant Adeno-associated Virus Containing VEGFR truncated soluble cDNA

- - Gene Therapeutic Agent of Cancer Comprising Recombinant Adeno-associated Virus Containing Antisense cDNAs of VEGF-A VEGF-B and VEGF-C and Recombinant Adeno-associated Virus Containing VEGFR truncated soluble cDNA

机译:--包含VEGF-A,VEGF-B和VEGF-C的反义cDNA的重组腺相关病毒和含VEGFR截短的可溶性cDNA的重组腺相关病毒的癌症基因治疗剂

摘要

The present invention is a gene therapy of cancer comprising the rAAV vector containing the soluble incomplete (truncated soluble) cDNA of the rAAV vector and VEGF receptor protein (VEGFR) containing the anti-sense cDNA of VEGF-A, VEGF-B, and VEGF-C to relate. ; Gene therapy according to the present invention can be used effectively in the treatment of cancer by inhibiting the expression of VEGF and functions involved in angiogenesis is essential for the proliferation and metastasis, by reducing the growth of tumors in the gene level. ; rAAV, gene therapy, VEGF, VEGF receptor, adeno-associated virus
机译:本发明是一种癌症的基因疗法,其包含含有rAAV载体的可溶性不完全(截短的可溶性)cDNA的rAAV载体和含有VEGF-A,VEGF-B和VEGF的反义cDNA的VEGF受体蛋白(VEGFR)。 -C关联。 ;通过抑制VEGF的表达,本发明的基因疗法可以有效地用于癌症的治疗,并且通过降低基因水平上的肿瘤的生长,参与血管生成的功能对于增殖和转移是必不可少的。 ; rAAV,基因治疗,VEGF,VEGF受体,腺相关病毒

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号